Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction

Agri

Volumn 17, Issue 3, 2005, Pages 44-47

  Takmaz, Suna Akin ^a,b,c   Inan, Nurten ^a,c   Günal, Solmaz ^a,c   Kaymak, Çetin ^a,c   Sakalli, Melike ^a,c   Dikmen, Bayazit ^a,d  

^a MINISTRY OF HEALTH   (Turkey)

^b Anesteziyoloji ve Reanimasyon Kliniǧi ^*  (Turkey)

^c Ankara E itim ve Ara tirma Hastanesi   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Addiction; Ketamine; Meperidine; Morphine; NMDA receptor; Tolerance

Indexed keywords

CHLORPROMAZINE; DICLOFENAC; DIPYRONE; KETAMINE; MORPHINE; PETHIDINE;

ADULT; ANAMNESIS; ARTICLE; CANCER PAIN; CASE REPORT; DRUG DEPENDENCE; DRUG TOLERANCE; HUMAN; MALE; PAIN ASSESSMENT; SPINE METASTASIS; TERMINALLY ILL PATIENT; VISUAL ANALOG SCALE;

EID: 25444518477     PISSN: 13000012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Arendt-Nielsen L., Petersen-Felix S., Fischer M.: The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli. Anesth Analg 1995; 81: 63-68.
2. Bell R.: Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 1999; 83: 101-103.
3. Celerier E., Rivat C., Jun Y., Laulin J. P., Larcher A., Reynier P., Simonnet G.: Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000; Feb 92: 2: 465-472.
4. Cherry D. A., Plummer J. L., Gourlay G. K., Coates K. R., Odgers C. L.: Ketamine as an adjunt to morphine in the treatment of pain. Pain 1995; 62: 119-121.
5. Clark J. L., Kalan G. E.: Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage 1995; 10: 310-314.
6. Enarson M., Hays H., Woodroffe M. A.: Clinical experience with oral ketamine. J Pain Symptom Manage 1999; 17: 384-386.
7. Fine P. G.: Low dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage 1999; 17: 296-300.
8. Gonzalez P., Cabello P., Germany A., Morris B., Contreras E.: Decrease of tolerance to, and physical dependence on morphine by glutamate receptor antagonists. Eur J Pharmacol 1997; 332: 257-262.
9. Herman B. H., Vocci F., Bridge P.: The effects of NMDA receptor antagonists and nitric oxide synthesis inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 1995; 13: 269-293.
10. Mao J., Price D. D., Mayer D. J.: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactins. Pain 1995; 62: 259-274.
11. Mayer D. J., Mao J., Price D. D.: The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C. NIDA Res Monogr 1995; 147: 269-298.
12. Mercadante S., Lodi F., Sapio M., Calligara M., Serretta R.: Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995; 10: 564-568.
13. Price D.D., Mao J., Mayer D.: Central consequences of persistent pain states. In: Jensen T. S., Turner J. A., Wiesenfeld-Hallin Z. editors. Proc. Of the 8th World Cong Of Pain: Progress in Pain Research and Management. Seattle: IASP Press, 1997. pp. 155-184.
14. Rapp S. E., Ready L. B., Nessly M. L.: Acute pain management in patients with prior opioid consumption. Pain 1995; 61: 195-201.
15. Schimoyama N., Intumisi C. E., Eliot K. J.: Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 1996; 85: 1357-1366.
16. Stocking R. K.: Nonbarbiturate Induction Drugs. In: Pharmacology and Physiology in Anesthetic Practice, 2nd edition. Philadelphia: Lippincott Williams and Wilkins, 2000. pp. 148-154.